Diversified, LLC Astrazeneca PLC Transaction History

Diversified, LLC

$804 Million
Q2 2024

A detailed history of Diversified, LLC transactions in Astrazeneca PLC stock. As of the latest transaction made, Diversified, LLC holds 4,213 shares of AZN stock, worth $300,892. This represents 0.04% of its overall portfolio holdings.

Number of Shares

4,213

Previous 3,839 9.74%

Holding current value

$300,892

Previous $260,000 26.15%

% of portfolio

0.04%

Previous 0.04%

13 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2024 Jul 24, 2024	BUY	$66.81 - $80.83 $24,986 - $30,230	374 Added 9.74%	4,213 $328,000
Q1 2024 May 02, 2024	SELL	$61.03 - $69.57 $22,398 - $25,532	-367 Reduced 8.73%	3,839 $260,000
Q4 2023 Feb 01, 2024	SELL	$61.89 - $69.28 $13,801 - $15,449	-223 Reduced 5.03%	4,206 $283,000
Q3 2023 Nov 02, 2023	BUY	$64.85 - $71.7 $9,014 - $9,966	139 Added 3.24%	4,429 $299,000
Q2 2023 Jul 26, 2023	SELL	$69.91 - $75.81 $4,334 - $4,700	-62 Reduced 1.42%	4,290 $307,000
Q1 2023 Apr 24, 2023	SELL	$63.15 - $71.6 $3,346 - $3,794	-53 Reduced 1.2%	4,352 $302,000
Q4 2022 Feb 13, 2023	BUY	$54.21 - $70.44 $17,401 - $22,611	321 Added 7.86%	4,405 $298,000
Q3 2022 Oct 25, 2022	BUY	$53.02 - $135.75 $212 - $543	4 Added 0.1%	4,084 $224,000
Q1 2022 Apr 14, 2022	BUY	$55.72 - $67.12 $7,745 - $9,329	139 Added 3.53%	4,080 $271,000
Q3 2021 Nov 04, 2021	BUY	$55.56 - $60.79 $888 - $972	16 Added 0.41%	3,941 $237,000
Q2 2021 Jul 16, 2021	BUY	$48.42 - $60.18 $190,048 - $236,206	3,925 New	3,925 $235,000
Q1 2021 May 05, 2021	SELL	$47.16 - $54.44 $183,263 - $211,553	-3,886 Closed	0 $0
Q4 2020 Jan 26, 2021	BUY	$48.52 - $58.02 $188,548 - $225,465	3,886 New	3,886 $213,000

Others Institutions Holding AZN

# of Institutions

1,345

Shares Held

492M

Call Options Held

4.99M

Put Options Held

3.18M

View Full List

About ASTRAZENECA PLC

Ticker AZN
Exchange OTC
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 3,099,020,032
Market Cap $221B
Description
AstraZeneca PLC, a biopharmaceutical company, focuses on the discovery, development, manufacturing, and commercialization of prescription medicines. Its marketed products include Calquence, Enhertu, Faslodex, Imfinzi, Iressa, Koselugo, Lumoxiti, Lynparza, Orpathys, Tagrisso, and Zoladex for oncology; Brilinta/Brilique, Bydureon/Byetta, BCise, By...

More about AZN

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Diversified, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Diversified, LLC with notifications on news.

Account